PTC Therapeutics, Inc.

Q2 2019 13F Holders

Symbol
PTCT
CUSIP
69366J200
Type
Equity
Class
COM
Num filings
202
Total reported value, excl. options
$2.63 B
Manager Report Date Value ($000) Shares Option Type